These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10606838)

  • 1. Effect of caffeine on clozapine pharmacokinetics in healthy volunteers.
    Hägg S; Spigset O; Mjörndal T; Dahlqvist R
    Br J Clin Pharmacol; 2000 Jan; 49(1):59-63. PubMed ID: 10606838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.
    Raaska K; Raitasuo V; Laitila J; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):13-8. PubMed ID: 14725610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.
    Carrillo JA; Herraiz AG; Ramos SI; Benítez J
    J Clin Psychopharmacol; 1998 Aug; 18(4):311-6. PubMed ID: 9690697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism.
    Sachse C; Ruschen S; Dettling M; Schley J; Bauer S; Müller-Oerlinghausen B; Roots I; Brockmöller J
    Clin Pharmacol Ther; 1999 Oct; 66(4):431-8. PubMed ID: 10546928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia.
    Frazier JA; Cohen LG; Jacobsen L; Grothe D; Flood J; Baldessarini RJ; Piscitelli S; Kim GS; Rapoport JL
    J Clin Psychopharmacol; 2003 Feb; 23(1):87-91. PubMed ID: 12544379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of interaction between erythromycin and a single dose of clozapine.
    Hägg S; Spigset O; Mjörndal T; Granberg K; Persbo-Lundqvist G; Dahlqvist R
    Eur J Clin Pharmacol; 1999 May; 55(3):221-6. PubMed ID: 10379638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
    Perera V; Gross AS; Xu H; McLachlan AJ
    J Pharm Pharmacol; 2011 Sep; 63(9):1161-8. PubMed ID: 21827488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline has no advantages over caffeine as a putative model drug for assessing CYPIA2 activity in humans.
    Rasmussen BB; Brøsen K
    Br J Clin Pharmacol; 1997 Mar; 43(3):253-8. PubMed ID: 9088579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers.
    Wang CY; Zhang ZJ; Li WB; Zhai YM; Cai ZJ; Weng YZ; Zhu RH; Zhao JP; Zhou HH
    J Clin Pharmacol; 2004 Jul; 44(7):785-92. PubMed ID: 15199083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil-associated clozapine toxicity.
    Dequardo JR
    Am J Psychiatry; 2002 Jul; 159(7):1243-4. PubMed ID: 12091210
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
    Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
    J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exercise on plasma concentrations of caffeine and its metabolites in horses.
    Aramaki S; Suzuki E; Ishidaka O; Momose A
    Biol Pharm Bull; 1995 Nov; 18(11):1607-9. PubMed ID: 8593490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.
    Bertilsson L; Carrillo JA; Dahl ML; Llerena A; Alm C; Bondesson U; Lindström L; Rodriguez de la Rubia I; Ramos S; Benitez J
    Br J Clin Pharmacol; 1994 Nov; 38(5):471-3. PubMed ID: 7893591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathomimetic effects of paraxanthine and caffeine in humans.
    Benowitz NL; Jacob P; Mayan H; Denaro C
    Clin Pharmacol Ther; 1995 Dec; 58(6):684-91. PubMed ID: 8529334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine.
    Wilkinson JM; Pollard I
    Brain Res Dev Brain Res; 1993 Oct; 75(2):193-9. PubMed ID: 8261611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
    Elshafeey AH; Elsherbiny MA; Fathallah MM
    Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients.
    Chang WH; Lin SK; Lane HY; Wei FC; Hu WH; Lam YW; Jann MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):723-39. PubMed ID: 9723115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of caffeine on the pharmacokinetics of acetaminophen in man.
    Iqbal N; Ahmad B; Janbaz KH; Gilani AU; Niazi SK
    Biopharm Drug Dispos; 1995 Aug; 16(6):481-7. PubMed ID: 7579030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.